Strong results from Crohn’s disease drug trial send Celgene Corporation (NASDAQ: CELG) shares higher on Monday. The stock closed up 4.40% on nearly 8 million shares traded.  

For an in-depth report on Celgene Corporation follow: www.pennystocktitans.com/stockquote/CELG                                      

Celgene Corp. announced on Monday that it will present data on its Crohn's disease drug GED-0301 at a conference Tuesday. The company posted an abstract with top-line results on the high side of expectations.

Phase-2 trial of Crohn's disease drug Mongersen came in on the high side of expectations. Remission rates of 55% in the 40 mg group and 65% in the 160 mg group were compared to 9.5% in the placebo group.

The drug could be a blockbuster for the biotech company.



PennyStockTitans wants to help everyday people gain awareness about some of the hottest stocks trading in the stock market today. PennyStockTitans.com releases momentum alerts on companies that you may have never heard about or thought about looking at. Take a few minutes to register with us at http://www.pennystocktitans.com/ to get full access to our free stock reports.
 
 

Fannie Mae and Freddie Mac shareholder lawsuit pushes Federal National Mortgage Association (OTCBB: FNMA) shares to close up over 5% on Monday.

For an in-depth report on Federal National Mortgage Association follow: www.pennystocktitans.com/stockquote/FNMA                                     
   

A shareholder of Fannie Mae and Freddie Mac (FMCC) is suing the government and has filed a brief in federal court in Iowa. The shareholder is arguing that a federal judge in Washington, D.C. reached the wrong decision when he dismissed a similar case last month.

The filing marks the first time lawyers for plaintiffs in various Fannie and Freddie lawsuits have responded in detail to Judge Royce C. Lamberth’s decision.

It argues that Judge Lamberth made an error by allowing the Federal Housing Finance Agency more discretion in its role as a conservator than the law allows. It asks the Iowa court to give the Lamberth decision “no weight.”

Fannie and Freddie shares sank after the Lamberth decision
 
 


Disclosure: PennyStockTitans.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures. 
 
 
 

Celgene (NASDAQ:CELG)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Celgene Charts.
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Celgene Charts.